Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.1 USD | +0.16% | -4.98% | +21.51% |
09/05 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
421.86Cr | - | - | - | |||
12TCr | ||||||
11TCr | ||||||
2.42TCr | - | |||||
2.28TCr | - | |||||
1.8TCr |
- Stock Market
- Equities
- IBRX Stock
- Charts ImmunityBio, Inc.
- Sector Chart